CRON (STOCKS)
Cronos Group Inc. Common Share
$2.630000
-0.050000 (-1.87%)
Prev close: $2.680000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Other
- CEO
- Michael Ryan Gorenstein
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $988.96M
- Employees
- 459
- P/E (TTM)
- -609.09
- P/B (TTM)
- 0.94
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
6
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$0.04 | $0.00 | +0.0400 | +0.00% |
|
Dec 2025 (Q4)
|
$0.00 | $0.01 | -0.0142 | -139.22% |
|
Sep 2025 (Q3)
|
$0.08 | $0.00 | +0.0800 | +0.00% |
|
Jun 2025 (Q2)
|
$-0.10 | $-0.02 | -0.0796 | -390.20% |
Financial Statements
| Revenues | $159.54M |
| Benefits Costs and Expenses | $165.78M |
| Cost Of Revenue | $91.36M |
| Costs And Expenses | $165.78M |
| Gross Profit | $68.18M |
| Nonoperating Income/Loss | $8.91M |
| Operating Expenses | $83.33M |
| Depreciation and Amortization | $2.05M |
| Research and Development | $5.07M |
| Other Operating Expenses | $76.22M |
| Operating Income/Loss | -$15.16M |
| Income/Loss From Continuing Operations After Tax | $5.06M |
| Income/Loss From Continuing Operations Before Tax | -$6.25M |
| Income Tax Expense/Benefit | -$11.31M |
| Net Income/Loss | $5.06M |
| Net Income/Loss Attributable To Noncontrolling Interest | $6.88M |
| Net Income/Loss Attributable To Parent | -$1.82M |
| Net Income/Loss Available To Common Stockholders, Basic | -$588.00K |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $0.01 |
| Diluted Earnings Per Share | $0.01 |
| Basic Average Shares | 1,147,451,200 |
| Diluted Average Shares | 1,151,782,353 |
| Assets | $1.17B |
| Current Assets | $927.88M |
| Cash | $821.86M |
| Inventory | $48.68M |
| Other Current Assets | $57.34M |
| Noncurrent Assets | $244.23M |
| Fixed Assets | $142.10M |
| Intangible Assets | $8.55M |
| Other Non-current Assets | $93.58M |
| Liabilities | $48.30M |
| Current Liabilities | $42.42M |
| Accounts Payable | $10.28M |
| Other Current Liabilities | $32.14M |
| Noncurrent Liabilities | $5.88M |
| Equity | $1.12B |
| Equity Attributable To Noncontrolling Interest | $50.15M |
| Equity Attributable To Parent | $1.07B |
| Liabilities And Equity | $1.17B |
| Net Cash Flow From Operating Activities | $38.86M |
| Net Cash Flow From Operating Activities, Continuing | $38.86M |
| Net Cash Flow From Investing Activities | $16.83M |
| Net Cash Flow From Investing Activities, Continuing | $16.83M |
| Net Cash Flow From Financing Activities | -$35.24M |
| Net Cash Flow From Financing Activities, Continuing | -$35.24M |
| Exchange Gains/Losses | $3.59M |
| Net Cash Flow | $24.04M |
| Net Cash Flow, Continuing | $20.44M |
| Comprehensive Income/Loss | $38.92M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $8.20M |
| Comprehensive Income/Loss Attributable To Parent | $30.71M |
| Other Comprehensive Income/Loss | -$26.37M |